No difference in rate of adverse cardiovascular events when comparing anticoagulants
Thursday, May 18, 2017 - 11:01
in Health & Medicine
In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI), there was no significant difference in the rate of a composite of death, myocardial infarction and stroke whether they were anticoagulated with bivalirudin or unfractioned heparin, according to a study.